Endogenous cardioprotection by ischaemic postconditioning and remote conditioning

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 206-216

  Shi, Weiwei ^a   Vinten Johansen, Jakob ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Endothelium; Mitochondrial permeability transition pore; Myocardial infarction; Postconditioning; Preconditioning; Reperfusion injury

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ACIDOSIS; CELL SURVIVAL; COMORBIDITY; CONDITIONING; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

APOPTOSIS; HUMANS; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 84860123407     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs088     Document Type: Review

References (122)

1. Anderson JL, Marshall HW, Bray BE, Lutz JR, Frederick PR, Yanowitz FG et al. A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction. N Engl J Med 1983;308:1312-1318. (Pubitemid 13094602)
2. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to sixmonth mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-36. (Pubitemid 34059858)
3. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000;343:385-391. (Pubitemid 30626120)
4. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135.
5. Weman SM, Karhunen PJ, Penttila A, Jarvinen AA, Salminen US. Reperfusion injury associated with one-fourth of deaths after coronary artery bypass grafting. Ann Thorac Surg 2000;70:807-812.
6. Vinten-Johansen J, Jiang R, Reeves JG, Mykytenko J, Deneve J, Jobe LJ. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury. Hematol Oncol Clin North Am 2007;21:123-145. (Pubitemid 46156986)
7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136. (Pubitemid 17174962)
8. Manintveld OC, te Lintel HM, van den Bos EJ, Suurenbroek GM, Dekkers DH, Verdouw PD et al. Cardiac effects of postconditioning depend critically on the duration of index ischemia. Am J Physiol Heart Circ Physiol 2007;292:H1551- H1560. (Pubitemid 46377144)
9. Cai M, Li Y, Xu Y, Swartz HM, Chen CL, Chen YR et al. Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning. Am J Physiol Heart Circ Physiol 2011;300:H1069-H1077.
10. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004;62:74-85. (Pubitemid 38326813)
11. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588. (Pubitemid 36885888)
12. Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, Przyklenk K. The multidimensional physiological responses to postconditioning. Antioxid Redox Signal 2011;14:791-810.
13. Hansen PR, Thibault H, Abdulla J. Postconditioning during primary percutaneous coronary intervention: a review and meta-analysis. Int J Cardiol 2010;144:22-25.
14. Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 2011;8:619-629.
15. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA et al. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005;288:H1900-H1908. (Pubitemid 40418019)
16. Yang XM, Philipp S, Downey JM, Cohen MV. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005;100:57-63. (Pubitemid 40069107)
17. Halkos ME, Kerendi F, Corvera JS, Wang NP, Kin H, Payne CS et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004;78:961-969. (Pubitemid 39164812)
18. Hu X, Jiang H, Ma F, Xu C, Bo C, Wen H et al. Similarities between ischemic preconditioning and postconditioning in myocardial ischemia/reperfusion injury. Int J Cardiol 2010;144:135-136.
19. Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R et al. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release. Shock 2008;29:761-768. (Pubitemid 351769941)
20. Taki J, Higuchi T, Kawashima A, Fukuoka M, Kayano D, Tait JF et al. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. J Nucl Med 2007;48:1301-1307. (Pubitemid 47242795)
21. Wang HC, Zhang HF, Guo WY, Su H, Zhang KR, Li QX et al. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 2006;11:1453-1460. (Pubitemid 44035955)
22. Sun HY, Wang NP, Halkos M, Kerendi F, Kin H, Guyton RA et al. Postconditioning attenuates cardiomyocyte apoptosis via inhibition of JNK and p38 mitogen-activated protein kinase signaling pathways. Apoptosis 2006;11:1583-1593. (Pubitemid 44253675)
23. Penna C, Perrelli MG, Raimondo S, Tullio F, Merlino A, Moro F et al. Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta 2009;1787:794-801.
24. Tian Y, Zhang W, Xia D, Modi P, Liang D, Wei M. Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway. J Biomed Sci 2011;18:53.
25. Kin H, Zatta AJ, Lofye MT, Amerson BS, Halkos ME, Kerendi F et al. Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovasc Res 2005;67:124-133. (Pubitemid 40798299)
26. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 2008;294:H1444-H1451. (Pubitemid 351468744)
27. Xi L, Das A, Zhao ZQ, Merino VF, Bader M, Kukreja RC. Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation 2008;118:S32-S37.
28. Vinten-Johansen J, Shi W. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions. J Cardiovasc Pharmacol Ther 2011;16:260-266.
29. Vessey DA, Li L, Honbo N, Karliner JS. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre-and postconditioning. Am J Physiol Heart Circ Physiol 2009;297:H1429-H1435.
30. Litt MR, Jeremy RW,Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia: evidence for neutrophil-mediated reperfusion injury. Circulation 1989;80:1816-1827. (Pubitemid 20031713)
31. Winquist R, Frei P, Harrison P, McFarland M, Letts G, Van G et al. An anti-CD-18 Mab limits infarct size in primates following ischemia and reperfusion. Circulation 1990;82:III-701a.
32. Granfeldt A, Jiang R, Wang N-P, Mykytenko J, Eldaif SM, Deneve J et al. PMN inhibition contributes to cardioprotection by postconditioning. Acta Anaesth Scand 2012; 56:48-56.
33. Danielisova V, Nemethova M, Gottlieb M, Burda J. The changes in endogenous antioxidant enzyme activity after postconditioning. Cell Mol Neurobiol 2006;26: 1181-1191. (Pubitemid 44924039)
34. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004;44: 1111-1112. (Pubitemid 39165148)
35. Cohen MV, Yang XM, Downey JM. Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res Cardiol 2008;103:464-471.
36. Rodriguez-Sinovas A, Cabestrero A, Garcia del Blanco B, Inserte J, Garcia A, Garcia-Dorado D. Intracoronary acid infusion as an alternative to ischemic postconditioning in pigs. Basic Res Cardiol 2009;104:761-771.
37. Inserte J, Barba I, Hernando V, Garcia-Dorado D. Delayed recovery of intracellular acidosis during reperfusion prevents calpain activation and determines protection in postconditioned myocardium. Cardiovasc Res 2009;81:116-122.
38. Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H et al. Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 2007;292:H2004-H2008. (Pubitemid 46572427)
39. Inserte J, Barba I, Poncelas-Nozal M, Hernando V, Agullo L, Ruiz-Meana M et al. cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. J Mol Cell Cardiol 2011;50:903-909.
40. Hausenloy DJ, Lecour S, Yellon DM. Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 2011;14:893-907.
41. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010;87:406-423.
42. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res 2009;104:15-18.
43. Zhang Y, Lv F, Jin L, PengW, Song R, Ma J et al. MG53 participates in ischaemic postconditioning through the RISK signalling pathway. Cardiovasc Res 2011;91:108-115.
44. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM et al. Role of STAT3 in ischemic preconditioning. J Mol Cell Cardiol 2001;33:1929-1936. (Pubitemid 33097272)
45. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 2008;102:131-135.
46. Lacerda L, Somers S, Opie LH, Lecour S. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 2009;84:201-208.
47. Garlid KD, Costa AD, Quinlan CL, Pierre SV, Dos Santos P. Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 2009;46:858-866.
48. Boengler K, Heusch G, Schulz R. Mitochondria in postconditioning. Antioxid Redox Signal 2011;14:863-880.
49. Lim SY, Davidson SM, Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res 2007;75:530-535. (Pubitemid 47080966)
50. Gomez L, Paillard M, Thibault H, Derumeaux G, Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008;117:2761-2768. (Pubitemid 351770456)
51. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 2010;105:771-785.
52. Mykytenko J, Reeves JG, Kin H,Wang NP, Zatta AJ, Jiang R et al. Persistent beneficial effect of postconditioning against infarct size: role of mitochondrial K(ATP) channels during reperfusion. Basic Res Cardiol 2008;103:472-484.
53. Quinlan CL, Costa AD, Costa CL, Pierre SV, Dos Santos P, Garlid KD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol 2008;295:H953-H961.
54. Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 2007;75:168-177. (Pubitemid 46881061)
55. Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, Garlid KD. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem 2006;281:20801-20808. (Pubitemid 44115421)
56. Zhao JL, Yang YJ, You SJ, Cui CJ, Gao RL. Different effects of postconditioning on myocardial no-reflow in the normal and hypercholesterolemic mini-swines. Microvasc Res 2007;73:137-142.
57. Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W et al. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol 2009;297: H1729-H1735.
58. Iliodromitis EK, Zoga A, Vrettou A, Andreadou I, Paraskevaidis IA, Kaklamanis L et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006;188:356-362. (Pubitemid 44313925)
59. Donato M, D'Annunzio V, Berg G, Gonzalez G, Schreier L, Morales C et al. Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2007;49:287-292. (Pubitemid 46855122)
60. Zhao H, Wang Y, Wu Y, Li X, Yang G, Ma X et al. Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation. Acta Biochim Biophys Sin (Shanghai) 2009;41:745-753.
61. Yin Z, Gao H,Wang H, Li L, Di C, Luan R et al. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Clin Exp Pharmacol Physiol 2009;36:756-763.
62. Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 2008;51: 1393-1398. (Pubitemid 351443077)
63. Lauzier B, Delemasure S, Debin R, Collin B, Sicard P, Acar N et al. Beneficial effects of myocardial postconditioning are associated with reduced oxidative stress in a senescent mouse model. Transplantation 2008;85:1802-1808.
64. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005;65:361-367. (Pubitemid 40898179)
65. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I et al. Postconditioning the human heart. Circulation 2005;112:2143-2148. (Pubitemid 41475808)
66. Lonborg J, Holmvang L, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S et al. ST-segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. Am Heart J 2010;160:1085-1091.
67. Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 2008;72:212-220.
68. Zhao WS, Xu L, Wang LF, Zhang L, Zhang ZY, Liu Y et al. A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction. Apoptosis 2009;14:1204-1211.
69. Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
70. Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol 2007;102:274-278. (Pubitemid 46564075)
71. Ma XJ, Zhang XH, Li CM, Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function in patients with acute myocardial infarction. Scand Cardiovasc J 2006;40:327-333. (Pubitemid 44803884)
72. Wang G, Zhang S, Joggerst SJ, McPherson J, Zhao DX. Effects of the number and interval of balloon inflations during primary PCI on the extent of myocardial injury in patients with STEMI: does postconditioning exist in real-world practice? J Invasive Cardiol 2009;21:451-455.
73. Yang XC, Liu Y, Wang LF, Cui L, Wang T, Ge YG et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007;19:424-430. (Pubitemid 47509466)
74. Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, Saunamaki K et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010;3:34-41.
75. Downey JM, Cohen MV. Why do we still not have cardioprotective drugs? Circ J 2009;73:1171-1177.
76. Sorensson P, Saleh N, Bouvier F, Bohm F, Settergren M, Caidahl K et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010;96:1710-1715.
77. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2011; doi:10.1093/eurheartj/ehr297.
78. Kloner RA. Clinical application of remote ischemic preconditioning. Circulation 2009; 119:776-778.
79. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-899. (Pubitemid 23070821)
80. Pell TJ, Baxter GF, Yellon DM, Drew GM. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 1998;275:H1542-H1547.
81. Przyklenk K, Whittaker P. Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. J Cardiovasc Pharmacol Ther 2011;16: 255-259.
82. Wang Y, Xu H, Mizoguchi K, Oe M, Maeta H. Intestinal ischemia induces late preconditioning against myocardial infarction: a role for inducible nitric oxide synthase. Cardiovasc Res 2001;49:391-398. (Pubitemid 32119556)
83. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V et al. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 2004;19:143-150.
84. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A et al. Rabbit heart can be 'preconditioned' via transfer of coronary effluent. Am J Physiol Heart Circ Physiol 1999;277:H2451-H2457. (Pubitemid 30048169)
85. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 2009;117:191-200.
86. Dickson EW, Reinhardt CP, Renzi FP, Becker RC, Porcaro WA, Heard SO. Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence. J Thromb Thrombolysis 1999;8:123-129. (Pubitemid 29410837)
87. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 2008;79:377-386.
88. Shimizu M, Saxena P, Konstantinov IE, Cherepanov V, Cheung MM, Wearden P et al. Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. J Surg Res 2010;158:155-161.
89. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004;61:481-497. (Pubitemid 38210154)
90. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000;278:H1571-H1576. (Pubitemid 30395568)
91. Ding YF, Zhang MM, He RR. Role of renal nerve in cardioprotection provided by renal ischemic preconditioning in anesthetized rabbits. Sheng Li Xue Bao 2001;53: 7-12.
92. Kingma JG Jr, Simard D, Voisine P, Rouleau JR. Role of the autonomic nervous system in cardioprotection by remote preconditioning in isoflurane-anaesthetized dogs. Cardiovasc Res 2011;89:384-391.
93. Konstantinov IE, Li J, Cheung MM, Shimizu M, Stokoe J, Kharbanda RK et al. Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism. Transplantation 2005;79:1691-1695. (Pubitemid 40885266)
94. Heidbreder M, Naumann A, Tempel K, Dominiak P, Dendorfer A. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res 2008;78:108-115. (Pubitemid 351430955)
95. Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 2011; 106:135-145.
96. Serejo FC, Rodrigues LF Jr, da Silva Tavares KC, de Carvalho AC, Nascimento JH. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning. J Cardiovasc Pharmacol 2007;49:214-220. (Pubitemid 46626013)
97. Wolfrum S, Nienstedt J, Heidbreder M, Schneider K, Dominiak P, Dendorfer A. Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul Pept 2005;127:217-224. (Pubitemid 40179259)
98. Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009;374:1557-1565.
99. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106:2881-2883. (Pubitemid 35424735)
100. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation 2009;119:820-827.
101. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007; 370:575-579. (Pubitemid 47247853)
102. Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart 2009;95: 1567-1571.
103. Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L, Freiberger T. Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg 2010;11:758-762.
104. Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Klovgaard L, Kaltoft A et al. Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial. Circulation 2008;118: 1155-1162.
105. Schmidt MR, Smerup M, Konstantinov IE, Shimizu M, Li J, Cheung M et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. Am J Physiol Heart Circ Physiol 2007;292:H1883-H1890. (Pubitemid 46572412)
106. Xin P, Zhu W, Li J, Ma S, Wang L, Liu M et al. Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning. Am J Physiol Heart Circ Physiol 2010;298:H1819-H1831.
107. Bøtker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-734.
108. Rentoukas I, Giannopoulos G, Kaoukis A, Kossyvakis C, Raisakis K, Driva M et al. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv 2010;3: 49-55.
109. Li L, Luo W, Huang L, Zhang W, Gao Y, Jiang H et al. Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res 2010;164:e21-e26.
110. Kerendi F, Kin H, Halkos ME, Jiang R, Zatta AJ, Zhao ZQ et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 2005;100:404-412. (Pubitemid 41300495)
111. Andreka G, Vertesaljai M, Szantho G, Font G, Piroth Z, Fontos G et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs. Heart 2007;93:749-752. (Pubitemid 46808282)
112. Liu S, Wu XF, Zhang WZ, Sun YX, Cai SL. Remote postconditioning by brief renal ischemia and reperfusion reduces acute myocardial ischemia and reperfusion induced myocardial apoptosis in rabbits. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:757-760.
113. Gritsopoulos G, Iliodromitis EK, Zoga A, Farmakis D, Demerouti E, Papalois A et al. Remote postconditioning is more potent than classic postconditioning in reducing the infarct size in anesthetized rabbits. Cardiovasc Drugs Ther 2009;23:193-198.
114. Li CM, Zhang XH, Ma XJ, Luo M. Limb ischemic postconditioning protects myocardium from ischemia-reperfusion injury. Scand Cardiovasc J 2006;40:312-317. (Pubitemid 44501941)
115. Ma X, Zhang X, Li C, Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol 2006;19:367-375. (Pubitemid 44511065)
116. Xue F, Yang X, Zhang B, Zhao C, Song J, Jiang T et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010;33:439-444.
117. Lin XM, Zhang ZY, Wang LF, Zhang L, Liu Y, Liu XL et al. Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J (Engl) 2010;123: 1833-1839.
118. Gunaydin B, Cakici I, Soncul H, Kalaycioglu S, Cevik C, Sancak B et al. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res 2000;41:493-496.
119. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-2282. (Pubitemid 43795071)
120. Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, Kolocassides KG, Adamopoulos S, Karavolias G et al. Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? Heart 2006;92:1821-1826. (Pubitemid 44851332)
121. Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 2007;116: I98-I105. (Pubitemid 47480776)
122. Munk K, Andersen NH, Schmidt MR, Nielsen SS, Terkelsen CJ, Sloth E et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ Cardiovasc Imaging 2010;3: 656-662.